Optimizing Outcomes in the Virgin Penile Implant Patient.


Journal

Current urology reports
ISSN: 1534-6285
Titre abrégé: Curr Urol Rep
Pays: United States
ID NLM: 100900943

Informations de publication

Date de publication:
07 Feb 2019
Historique:
entrez: 8 2 2019
pubmed: 8 2 2019
medline: 23 2 2019
Statut: epublish

Résumé

Patient satisfaction with inflatable penile prosthesis (IPP) is an elective procedure that restores erectile function. While the return of usable erections is almost always achieved with IPP, patients may still be unhappy with the procedure if the outcome has not met their expectations. Optimizing patient satisfaction and outcomes should incorporate considerations for pre-, intra-, and postoperative factors. Length optimization regimens and improved pain control options have dominated the recent literature.

Identifiants

pubmed: 30729323
doi: 10.1007/s11934-019-0876-6
pii: 10.1007/s11934-019-0876-6
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

14

Références

J Urol. 1999 Dec;162(6):2054-7
pubmed: 10569568
Eur Urol. 2000 Jan;37(1):50-5
pubmed: 10671785
J Urol. 2000 Apr;163(4):1203-5
pubmed: 10737496
J Urol. 2003 Apr;169(4):1429-33
pubmed: 12629377
J Urol. 2003 Jul;170(1):159-63
pubmed: 12796670
Int J Impot Res. 2003 Oct;15 Suppl 5:S132-3
pubmed: 14551591
BJU Int. 2004 Jan;93(1):97-9
pubmed: 14678377
Int J Impot Res. 2005 Nov-Dec;17(6):535-8
pubmed: 15988544
Rev Urol. 2005;7 Suppl 2:S51-7
pubmed: 16985898
Eur Urol. 2007 Apr;51(4):1128-31
pubmed: 17084508
J Sex Med. 2007 Sep;4(5):1494-9
pubmed: 17727355
J Sex Med. 2010 Mar;7(3):1052-5
pubmed: 20500445
J Sex Med. 2011 Jul;8(7):2112-7
pubmed: 21492409
J Sex Med. 2011 Sep;8(9):2640-6
pubmed: 21679300
J Urol. 2011 Oct;186(4):1187-9
pubmed: 21849194
Adv Urol. 2012;2012:707321
pubmed: 22899909
J Sex Med. 2013 Apr;10(4):893-906; quiz 907
pubmed: 23551538
J Sex Med. 2014 Jan;11(1):273-8
pubmed: 24274160
Urology. 2014 Dec;84(6):1535-40
pubmed: 25432851
J Sex Med. 2015 May;12(5):1298-304
pubmed: 25872574
World J Urol. 2016 Jul;34(7):993-8
pubmed: 26475275
J Sex Med. 2016 Sep;13(9):1425-1431
pubmed: 27475239
Turk J Urol. 2016 Dec;42(4):230-234
pubmed: 27909614
J Sex Med. 2017 Jun;14(6):767-773
pubmed: 28583338
Int J Impot Res. 2017 Sep;29(5):215-218
pubmed: 28659631
J Sex Med. 2018 Apr;15(4):576-581
pubmed: 29523475
J Sex Med. 2018 Jun;15(6):914-919
pubmed: 29731427
Int J Impot Res. 2018 Aug;30(4):147-152
pubmed: 29795529
J Sex Med. 2018 Aug;15(8):1180-1186
pubmed: 30017718
J Sex Med. 2018 Aug;15(8):1187-1194
pubmed: 30017719
J Urol. 2019 Mar;201(3):581-586
pubmed: 30366022
BJU Int. 2018 Oct 30;:null
pubmed: 30378249
Urology. 1980 Jun;15(6):603-4
pubmed: 7394993
J Urol. 1995 Feb;153(2):366-7
pubmed: 7815585
J Urol. 1994 Aug;152(2 Pt 1):410-4
pubmed: 8015083
Urology. 1998 Dec;52(6):1106-12
pubmed: 9836564

Auteurs

Charles Welliver (C)

, Albany, USA. wellivr@amc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH